158 related articles for article (PubMed ID: 32215462)
1. Immunohistochemical assessment of symptomatic postmenopausal endometrial polyps in tamoxifen users and nonusers: a case control study.
Dibi RP; Zettler CG; Vanin CMM; Ribeiro RVP; Oliveira JM; Kremer TG; Borges J; Kato SK
Sao Paulo Med J; 2020; 138(1):64-68. PubMed ID: 32215462
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
3. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
[TBL] [Abstract][Full Text] [Related]
4. Differences in estrogen and progesterone receptor expression in endometrial polyps and atrophic endometrium of postmenopausal women with and without exposure to tamoxifen.
Leão RB; Andrade L; Vassalo J; Antunes A; Pinto-Neto A; Costa-Paiva L
Mol Clin Oncol; 2013 Nov; 1(6):1055-1060. PubMed ID: 24649292
[TBL] [Abstract][Full Text] [Related]
5. Effect of tamoxifen on postmenopausal endometrium.
Kalampokas T; Sofoudis C; Anastasopoulos C; Boutas I; Melloy S; Kondi-Pafiti A; Kalampokas E; Botsis D; Salakos N
Eur J Gynaecol Oncol; 2013; 34(4):325-8. PubMed ID: 24020139
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: comparison with postmenopausal polyps.
Altaner S; Gucer F; Tokatli F; Guresci S; Ozdemir C; Puyan FO; Kutlu K
Onkologie; 2006 Sep; 29(8-9):376-80. PubMed ID: 16974115
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
Inceboz US; Nese N; Uyar Y; Ozcakir HT; Kurtul O; Baytur YB; Kandiloglu AR; Caglar H; Fraser IS
Gynecol Obstet Invest; 2006; 61(1):24-8. PubMed ID: 16141722
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
Miranda SP; Traiman P; Cândido EB; Lages EL; Freitas GF; Lamaita RM; Vidigal PV; da Silva Filho AL
Int J Gynecol Cancer; 2010 Dec; 20(9):1525-30. PubMed ID: 21119367
[TBL] [Abstract][Full Text] [Related]
9. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.
Mourits MJ; Ten Hoor KA; van der Zee AG; Willemse PH; de Vries EG; Hollema H
J Clin Pathol; 2002 Jul; 55(7):514-9. PubMed ID: 12101196
[TBL] [Abstract][Full Text] [Related]
10. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Mar; 53(4):454-61. PubMed ID: 16169691
[TBL] [Abstract][Full Text] [Related]
12. Endometrial lesions after tamoxifen therapy in breast cancer women.
Maugeri G; Nardo LG; Campione C; Nardo F
Breast J; 2001; 7(4):240-4. PubMed ID: 11678801
[TBL] [Abstract][Full Text] [Related]
13. Sonographic, hysteroscopic, and histologic evaluation of the endometrium in postmenopausal women with breast cancer receiving tamoxifen.
Ceci O; Bettocchi S; Marello F; Nappi L; Chiechi LM; Laricchia L; Masciandaro A
J Am Assoc Gynecol Laparosc; 2000 Feb; 7(1):77-81. PubMed ID: 10648743
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
[TBL] [Abstract][Full Text] [Related]
16. Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifen-treated endometrium.
Hachisuga T; Hideshima T; Kawarabayashi T; Eguchi F; Emoto M; Shirakusa T
Int J Gynecol Pathol; 1999 Oct; 18(4):297-303. PubMed ID: 10542936
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium.
Mourits MJ; Hollema H; De Vries EG; Ten Hoor KA; Willemse PH; Van Der Zee AG
Hum Pathol; 2002 Mar; 33(3):341-6. PubMed ID: 11979376
[TBL] [Abstract][Full Text] [Related]
18. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
[TBL] [Abstract][Full Text] [Related]
19. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W
Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306
[TBL] [Abstract][Full Text] [Related]
20. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
Hann LE; Gretz EM; Bach AM; Francis SM
AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
